Nurse Practitioner · Knoxville, TN
NPI
1689774291
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1450 Dowell Springs Blvd, Suite 300
Knoxville, TN, 37909
Phone (865) 637-8812
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
2,616 services
Medicare patients, 2024
144
Average age 73
Drug cost, 2024
$2.7M
4,419 prescriptions
Company payments, 2025
$924
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gina L Bearden was code 36415 (venipuncture blood collection), 260 times for 141 patients. In total Gina L Bearden billed 2,616 services in 41 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 260 | 141 | $8.54 | $2,221 |
| 80053 Clinical Chemistry | Office | 253 | 141 | $10.26 | $2,595 |
| 84443 Clinical Chemistry | Office | 247 | 140 | $16.31 | $4,029 |
| 83036 Blood Count | Office | 245 | 137 | $9.44 | $2,313 |
| 84439 Clinical Chemistry | Office | 245 | 138 | $8.77 | $2,148 |
| 80061 Clinical Chemistry | Office | 243 | 136 | $13.07 | $3,175 |
| 99214 Office E&M - Established | Office | 188 | 109 | $71.75 | $13K |
| 95251 Test - Miscellaneous | Office | 128 | 78 | $19.69 | $2,520 |
| 82570 Clinical Chemistry | Office | 93 | 85 | $5.08 | $472 |
| 82043 Clinical Chemistry | Office | 93 | 85 | $5.66 | $526 |
| 82306 Clinical Chemistry | Office | 67 | 50 | $28.58 | $1,915 |
| 99215 Office E&M - Established | Office | 48 | 38 | $98.88 | $4,746 |
| 85027 Blood Count | Office | 16 | 15 | $6.34 | $101 |
| 83970 Clinical Chemistry | Office | 15 | 11 | $40.45 | $607 |
| 82607 Clinical Chemistry | Office | 14 | 13 | $14.78 | $207 |
By year: 2022 $93K for 4,683 services; 2023 $85K for 4,337 services; 2024 $51K for 2,616 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 260 | 141 | $8.54 | $2,221 |
| 80053 Clinical Chemistry | 253 | 141 | $10.26 | $2,595 |
| 84443 Clinical Chemistry | 247 | 140 | $16.31 | $4,029 |
| 84439 Clinical Chemistry | 245 | 138 | $8.77 | $2,148 |
| 83036 Blood Count | 245 | 137 | $9.44 | $2,313 |
| 80061 Clinical Chemistry | 243 | 136 | $13.07 | $3,175 |
| 82570 Clinical Chemistry | 93 | 85 | $5.08 | $472 |
| 82043 Clinical Chemistry | 93 | 85 | $5.66 | $526 |
| 82306 Clinical Chemistry | 67 | 50 | $28.58 | $1,915 |
| 85027 Blood Count | 16 | 15 | $6.34 | $101 |
Medicare prescription drug claims, 2024
In 2024, the drug Gina L Bearden prescribed most often to Medicare patients was Levothyroxine Sodium, with 283 prescriptions and refills. In total Gina L Bearden wrote 4,419 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 283 | 818 | 89 | $2,637 |
| Metformin Hcl Er Metformin Hcl | 233 | 665 | 77 | $3,128 |
| Mounjaro Tirzepatide | 232 | 391 | 63 | $406K |
| Tresiba Flextouch U-200 Insulin Degludec | 229 | 523 | 84 | $500K |
| Atorvastatin Calcium Generic | 221 | 602 | 72 | $2,267 |
| Ezetimibe Generic | 197 | 528 | 70 | $5,047 |
| Ozempic Semaglutide | 197 | 374 | 67 | $346K |
| Rosuvastatin Calcium Generic | 179 | 529 | 64 | $2,795 |
| Jardiance Empagliflozin | 164 | 388 | 59 | $214K |
| Glimepiride Generic | 158 | 391 | 45 | $1,382 |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 156 | 329 | 69 | $259K |
| Telmisartan Generic | 132 | 341 | 42 | $2,824 |
| Losartan Potassium Generic | 121 | 361 | 42 | $1,407 |
| Tresiba Flextouch U-100 Insulin Degludec | 119 | 273 | 50 | $132K |
| Amlodipine Besylate Generic | 115 | 321 | 37 | $514 |
Brand drugs: 1,885 claims; generic drugs: 2,214 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gina L Bearden $924 ($924 in general payments such as food, travel and fees) from 18 companies. The largest payer was Novartis Pharmaceuticals Corporation with $176.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 12 | $176 |
| Xeris Pharmaceuticals, Inc. | 6 | $127 |
| Insulet Corporation PODD | 5 | $115 |
| Radius Health, Inc. | 4 | $91.1 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $52.54 |
| Abbott Laboratories ABT | 3 | $45.83 |
| Lilly USA, LLC LLY | 3 | $42.17 |
| Novo Nordisk Inc NVO | 2 | $31.26 |
| Amgen Inc. AMGN | 2 | $30.86 |
| CeQur Corporation | 1 | $30.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.